专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2007128568A1 BICYCLIC DERIVATIVES AS CETP INHIBITORS 审中-公开
标题翻译：双酚衍生物作为CETP抑制剂
公开(公告)号：WO2007128568A1
公开(公告)日：2007-11-15
申请号：PCT/EP2007/004058
申请日：2007-05-08
申请人： NOVARTIS AG , NOVARTIS PHARMA GMBH , KISHIDA, Masashi , MATSUURA, Naoko , IMASE, Hidetomo , IWAKI, Yuki , UMEMURA, Ichiro , OHMORI, Osamu , KAWAHARA, Eiji
发明人： KISHIDA, Masashi , MATSUURA, Naoko , IMASE, Hidetomo , IWAKI, Yuki , UMEMURA, Ichiro , OHMORI, Osamu , KAWAHARA, Eiji
IPC分类号： C07D401/12 , C07D401/14 , C07D471/04 , A61K31/4427 , A61P9/00
CPC分类号： C07D471/04 , C07D401/12 , C07D401/14
摘要： The present invention relates to novel compounds of formula (I): or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
摘要翻译：本发明涉及新的式（I）化合物：或其药物组合物，其全部变量在本文中定义。本发明还涉及本文中的化合物用于治疗或延缓进展到涉及CETP的疾病的公开。

2. 发明申请

WO2007073934A1 PYRIDINYL AMINE DERIVATIVES AS INHIBITORS OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) 审中-公开
标题翻译：作为胆固醇转运蛋白（CETP）的抑制剂的吡啶胺衍生物
公开(公告)号：WO2007073934A1
公开(公告)日：2007-07-05
申请号：PCT/EP2006/012540
申请日：2006-12-27
申请人： NOVARTIS AG , NOVARTIS PHARMA GMBH , SAKAKI, Junichi , KISHIDA, Masashi , MATSUURA, Naoko , UMEMURA, Ichiro , KAWAHARA, Eiji , YAMADA, Ken , KONISHI, Kazuhide , IWAKI, Yuki , IMASE, Hidetomo , MIYAKE, Takahiro
发明人： SAKAKI, Junichi , KISHIDA, Masashi , MATSUURA, Naoko , UMEMURA, Ichiro , KAWAHARA, Eiji , YAMADA, Ken , KONISHI, Kazuhide , IWAKI, Yuki , IMASE, Hidetomo , MIYAKE, Takahiro
IPC分类号： C07D213/38 , C07D213/40 , C07D401/12 , A61K31/44 , A61K31/4439 , A61P3/00 , A61P9/00
CPC分类号： C07D401/12 , C07D213/74 , C07D401/14 , C07D405/14 , C07D409/14
摘要： The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables are as defined, useful as inhibitors of chlosteryl ester transfer protein.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐，其中变量如上所定义，可用作chlosteryl ester transfer protein的抑制剂。

3. 发明申请

WO2006021454A2 PYRIMIDINE DERIVATIVES 审中-公开
公开(公告)号：WO2006021454A2
公开(公告)日：2006-03-02
申请号：PCT/EP2005/009251
申请日：2005-08-26
申请人： NOVARTIS AG , NOVARTIS PHARMA GmbH , IMBACH, Patricia , KAWAHARA, Eiji , KONISHI, Kazuhide , MATSUURA, Naoko , MIYAKE, Takahiro , OHMORI, Osamu , ROESEL, Johannes , TENO, Naoki , UMEMURA, Ichiro
发明人： IMBACH, Patricia , KAWAHARA, Eiji , KONISHI, Kazuhide , MATSUURA, Naoko , MIYAKE, Takahiro , OHMORI, Osamu , ROESEL, Johannes , TENO, Naoki , UMEMURA, Ichiro
IPC分类号： C07D239/48 , C07D401/12 , C07D403/12 , C07D413/12 , C07D403/14 , C07D401/14 , C07D498/04 , C07D409/12 , C07D409/14 , A61K31/505 , A61K31/506 , A61P35/00
CPC分类号： C07D239/48 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D409/12 , C07D409/14 , C07D413/12
摘要： Novel pyrimidine derivatives of formula (I) to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

4. 发明申请

WO2005016894A1 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS 审中-公开
标题翻译： 2，4-PYRIMININEDIAMINES有用的治疗神经疾病，炎症和免疫系统疾病
公开(公告)号：WO2005016894A1
公开(公告)日：2005-02-24
申请号：PCT/EP2004/009099
申请日：2004-08-13
申请人： NOVARTIS AG , NOVARTIS PHARMA GMBH , IRM LLC , GARCIA-ECHEVERRIA, Carlos , KANAZAWA, Takanori , KAWAHARA, Eiji , MASUYA, Keiichi , MATSUURA, Naoko , MIYAKE, Takahiro , OHMORI, Osamu , UMEMURA, Ichiro , STEENSMA, Ruo , CHOPIUK, Greg , JIANG, Jiqing , WAN, Yongqin , DING, Qiang , ZHANG, Qiong , GRAY, Nathanael, Schiander , KARANEWSKY, Donald
发明人： GARCIA-ECHEVERRIA, Carlos , KANAZAWA, Takanori , KAWAHARA, Eiji , MASUYA, Keiichi , MATSUURA, Naoko , MIYAKE, Takahiro , OHMORI, Osamu , UMEMURA, Ichiro , STEENSMA, Ruo , CHOPIUK, Greg , JIANG, Jiqing , WAN, Yongqin , DING, Qiang , ZHANG, Qiong , GRAY, Nathanael, Schiander , KARANEWSKY, Donald
IPC分类号： C07D239/48
CPC分类号： C07D239/48 , C04B35/632 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14
摘要： Novel pyrimidine derivatives of formula (I) Wherein R is selected from C 16-10 aryl, C5-10 heteroaryl, C 3-12 cycloalkyl and C 3-10 heterocycloalkyl; R 0 -R 6 as described herein; and their use for the manufacture of a medicament for the treatment or prevention of a disease wich responds to inhibition of FAK and/or ALK and/or ZAP-70 and/or IGF-IR.
摘要翻译：式（I）的新型嘧啶衍生物其中R选自C16-10芳基，C5-10杂芳基，C3-12环烷基和C3-10杂环烷基; R 0 -R 6，如本文所述; 以及它们用于制备用于治疗或预防对FAK和/或ALK和/或ZAP-70和/或IGF-1R的抑制作出反应的疾病的药物的用途。

5. 发明申请

WO2004080980A1 2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS 审中-公开
标题翻译： 2，4-二（苯基）氨基吡啶类药物治疗神经疾病，炎症和免疫系统疾病
公开(公告)号：WO2004080980A1
公开(公告)日：2004-09-23
申请号：PCT/EP2004/002616
申请日：2004-03-12
申请人： NOVARTIS AG , NOVARTIS PHARMA GMBH , GARCIA-ECHEVERRIA, Carlos , KANAZAWA, Takanori , KAWAHARA, Eiji , MASUYA, Keiichi , MATSUURA, Naoko , MIYAKE, Takahiro , OHMORI, Osamu , UMEMURA, Ichiro
发明人： GARCIA-ECHEVERRIA, Carlos , KANAZAWA, Takanori , KAWAHARA, Eiji , MASUYA, Keiichi , MATSUURA, Naoko , MIYAKE, Takahiro , OHMORI, Osamu , UMEMURA, Ichiro
IPC分类号： C07D239/48
CPC分类号： C07D401/12 , C07D239/48 , C07D401/14
摘要： Novel pyrimidine derivatives of formula (I), to processes for their production, their use as pharmaceuticals in the treatment of neoplastic diseases, inflammatory and immune system disorders and to pharmaceutical compositions comprising them.
摘要翻译：式（I）的新型嘧啶衍生物，其制备方法，其作为药物用于治疗肿瘤性疾病，炎性和免疫系统疾病的用途以及包含它们的药物组合物。

6. 发明申请

WO2006021457A2 PYRIMIDINE DERIVATIVES 审中-公开
标题翻译：嘧啶衍生物
公开(公告)号：WO2006021457A2
公开(公告)日：2006-03-02
申请号：PCT/EP2005/009255
申请日：2005-08-26
申请人： NOVARTIS AG , NOVARTIS PHARMA GMBH , KAWAHARA, Eiji , MIYAKE, Takahiro , ROESEL, Johannes
发明人： KAWAHARA, Eiji , MIYAKE, Takahiro , ROESEL, Johannes
IPC分类号： C07D239/48 , C07D401/14 , C07D403/12 , C07D403/14 , C07D498/04
CPC分类号： C07D239/48 , C07D401/14 , C07D403/12 , C07D403/14
摘要： Novel pyrimidine derivatives of formula (I) to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
摘要翻译：式（I）的新型嘧啶衍生物用于其生产的方法，其作为药物的用途以及包含它们的药物组合物。

7. 发明申请

WO2005025191A1 MOBILE TERMINAL AND INCOMING/OUTGOING CALL HISTORY MANAGEMENT METHOD 审中-公开
标题翻译：移动终端和接收/呼出呼叫历史管理方法
公开(公告)号：WO2005025191A1
公开(公告)日：2005-03-17
申请号：PCT/JP2004/012808
申请日：2004-08-27
申请人： MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. , HAMANAGA, Ayaka , KAWAHARA, Eiji
发明人： HAMANAGA, Ayaka , KAWAHARA, Eiji
IPC分类号： H04M1/57
CPC分类号： H04M1/56 , H04M1/274583 , H04M1/575 , H04M1/6505 , H04M1/72519 , H04M2250/10 , H04M2250/12 , H04M2250/52 , H04M2250/60
摘要： An incoming/outgoing call detection section (31) detects an incoming or outgoing phone call from or to another mobile terminal. An information acquisition section (32) acquires related information concerning an incoming or outgoing call in response to detection of the incoming or outgoing call by the detection section. An incoming/outgoing call history generation section (33) generate history information in which the related information acquired by the information acquisition section (32) is kept in association with at least a telephone number of the incoming or outgoing call. An incoming/outgoing call history storing section (34) stores the history information generated by the history generation section (33). An incoming/outgoing call history notification section (35) notifies to a user of the mobile terminal the related information contained in the history information, in response to an incoming or outgoing call from or to the telephone number contained in the history information stored in the incoming/outgoing call history storing section (34).
摘要翻译：进入/离开呼叫检测部分（31）检测来自或到另一个移动终端的进入或离开的电话呼叫。信息获取部分（32）响应于检测部分的呼入或呼出呼叫的检测，获取有关进入或离开呼叫的相关信息。输入/输出呼叫历史生成部分生成历史信息，其中由信息获取部分（32）获取的相关信息与至少输入或去电呼叫的电话号码保持关联。进入/离开呼叫历史存储部分（34）存储由历史生成部分（33）生成的历史信息。输入/输出呼叫历史通知部分（35）响应于从存储在所述历史信息中的历史信息中包含的电话号码的呼入或拨出呼叫向用户通知移动终端所包含的相关信息呼入/呼出历史存储部分（34）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式